Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome

References

• Aswini R, Jayapalan S. 2017. Modified Ferriman–gallwey score in Hirsutism and its association with metabolic syndrome. Int J Trichology. 9(1):7–13.
   PubMedGoogle Scholar
• Badawy A, Elnashar A. 2011. Treatment options for polycystic ovary syndrome. Int J Womens Health. 2011:25.
   Google Scholar
• Baldani DP, Skrgatić L, Goldstajn MS, Zlopasa G, Oguić SK, Canić T, Piljek AN. 2012. Clinical and biochemical characteristics of polycystic ovary syndrome in croatian population. Coll Antropol. 36(4):1413–1418.
   PubMedGoogle Scholar
• Banaszewska B, Spaczyński RZ, Pelesz M, Pawelczyk L. 2003. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia. Annales Academiae Medicae Bialostocensis. 48:131–134.
   Google Scholar
• Baptiste CG, Battista MC, Trottier A, Baillargeon JP. 2010. Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol. 122:42–52.
   PubMed Web of Science ®Google Scholar
• Cahoreau C, Klett D, Combarnous Y. 2015. Structure–function relationships of glycoprotein hormones and their subunits’ ancestors. Front Endocrinol (Lausanne). 6:26.
   PubMed Web of Science ®Google Scholar
• Chang PL, Lindheim SR, Lowre C, Ferin M, Gonzalez F, Berglund L, Carmina E, Sauer MV, Lobo RA. 2000. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing. J Clin Endocrinol Metab. 85(3):995–1000.
   PubMed Web of Science ®Google Scholar
• Choia J, Smitz J. 2014. Luteinizing hormone and human chorionic gonadotropin: origins of difference. Mol Cell Endocrinol. 383(1–2):203–213.
   PubMed Web of Science ®Google Scholar
• Cui J, Miner BM, Eldredge JB, Warrenfeltz SW, Dam P, Xu Y, Puett D. 2011. Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation. BMC Cancer. 11:280.
   PubMed Web of Science ®Google Scholar
• El‐Shal AS, Zidan HE, Rashad NM, Ahmed M. 2016. Association between genes encoding components of the Leutinizing hormone/Luteinizing hormone–choriogonadotrophin receptor pathway and polycystic ovary syndrome in Egyptian women. IUBMB Life. 68(1):23–36.
   PubMed Web of Science ®Google Scholar
• Elter K, Erel CT, Cine N, Ozbek U, Hacihanefioglu B, Ertungealp E. 1999. Role of the mutations Trp8 ≤ Arg and Ile15 ≤ Thr of the human luteinizing hormone beta-subunit in women with polycystic ovary syndrome. Fertil Steril. 71(3):425–430.
   PubMed Web of Science ®Google Scholar
• Englbrecht M, Alten R, Aringer M, Baerwald CG, Burkhardt H, Eby N, Fliedner G, Gauger B, Henkemeier U, Hofmann MW. 2017. Validation of standardized questionnaires evaluating symptoms of depression in rheumatoid arthritis patients: approaches to screening for a frequent yet underrated challenge. Arthritis Care Res. 69(1):58–66.
   Web of Science ®Google Scholar
• Filicori M. 1999. The role of luteinizing hormone in folliculogenesis and ovulation induction. Fertil Steril. 71(3):405–414.
   PubMed Web of Science ®Google Scholar
• Gilbert EW, Tay CT, Hiam DS, Teede HJ, Moran LJ. 2018. Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews. Clin Endocrinol. 89(6):683–699.
   PubMed Web of Science ®Google Scholar
• Jianga X, Dias JA, He X. 2014. Structural biology of glycoprotein hormones and their receptors: insights to signaling. Mol Cell Endocrinol. 382(1):424–451.
   PubMed Web of Science ®Google Scholar
• Kadhim MS. 2017. Serum Ghrelin, LH and FSH concentrations during menstrual cycle in non-obese PCOS women compared to healthy women. Biomed Pharmacol J. 10(4):4462–4468.
   Google Scholar
• Kumar P, Sait SF. 2011. Luteinizing hormone and its dilemma in ovulation induction. J Hum Reprod Sci. 4(1):2–7.
   PubMedGoogle Scholar
• Lal L, Bharti A, Perween A. 2017. To study the status of LH: FSH ratio in obese and non-obese patients of polycystic ovarian syndrome. Iosr-Jdms. 16:20–23.
   Google Scholar
• Liu N, Ma Y, Wang S, Zhang X, Zhang Q, Zhang X, Zhang X, Fu L, Qiao J. 2012. Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome. Reprod Biol Endocrinol. 10:36.
   PubMed Web of Science ®Google Scholar
• Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova JL, Azziz R. 2016. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 106(1):0015–0282.
   Web of Science ®Google Scholar
• Marisol SV, Vicente BC. 2015. Correlation between anti-mullerian hormone levels and antral follicle numbers in polycystic ovary syndrome. Sri Lanka Journal of Obstetrics and Gynaecology. 36(4):89–92.
   Google Scholar
• Montazeri A, Harirchi AM, Shariati M, Garmaroudi G, Ebadi M, Fateh A. 2003. The 12-item General Health Questionnaire (GHQ-12): translation and validation study of the Iranian version. Health Qual Life Outcomes. 13(1):66.
   Google Scholar
• Pache TD, De Jong FH, Hop WC. 1993. Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome. Fertil Steril. 59(3):544–549.
   PubMed Web of Science ®Google Scholar
• Palomba S, Santagni S, Falbo A, La Sala GB. 2015. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health. 7:745–763.
   PubMed Web of Science ®Google Scholar
• Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S, Mason H. 2007. Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab. 92(1):240–245.
   PubMed Web of Science ®Google Scholar
• Rackow BW, Brink HV, Hammers L, Flannery CA, Lujan ME, Burgert TS. 2018. Ovarian morphology by transabdominal ultrasound correlates with reproductive and metabolic disturbance in adolescents with PCOS. J Adolesc Health. 62(3):288–293.
   PubMed Web of Science ®Google Scholar
• Rajkhowa M, Talbot JA, Jones PW, Pettersson K, Haavisto AM, Huhtaniemi I, Clayton RN. 1995. Prevalence of an immunological LH ??-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome. Clin Endocrinol. 43(3):297–303.
   PubMed Web of Science ®Google Scholar
• Ramanujam LN, Liao WX, Roy AC, Loganath A, Goh HH, Ng SC. 1999. Association of molecular variants of luteinizing hormone with menstrual disorders. Clin Endocrinol. 51(2):243–246.
   PubMed Web of Science ®Google Scholar
• Robeva R, Andonova S, Tomova A, Kumanov P, Savov A. 2018. LHCG receptor polymorphisms in PCOS patients. Biotechnol Biotechnol Equip. 32:427–432.
   Web of Science ®Google Scholar
• Schmitz CG, Bastos de Souza CA, Genro VK, Matte U, de Conto E, Js C-F. 2015. LH (Trp8Arg/Ile15Thr), LHR (insLQ) and FSHR (Asn680Ser) polymorphisms genotypic prevalence in women with endometriosis and infertility. J Assist Reprod Genet. 32(6):991–997.
   PubMed Web of Science ®Google Scholar
• Soni A, Shivali S, Sachin G. 2018. polycystic ovary syndrome: pathogenesis, treatment and secondary associated diseases. J Drug Deliv Ther. 8:107–112.
   Google Scholar
• Suganuma N, Furui K, Furuhashi M, Asada Y, Kikkawa F, Tomoda Y. 1995. Screening of the mutations in luteinizing hormone β-subunit in patients with menstrual disorders. Fertil Steril. 63(5):989–995.
   PubMed Web of Science ®Google Scholar
• Tapanainen JS, Koivunen R, Fauser BC, Taylor AE, Clayton RN, Rajkowa M, White D, Franks S, Anttila L, Pettersson KS, et al. 1999. A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone. J Clin Endocrinol Metab. 84(5):1711–1715.
   PubMed Web of Science ®Google Scholar
• Thathapudi S, Kodati V, Erukkambattu J, Addepally U, Qurratulain H. 2015. Association of luteinizing hormone chorionic gonadotropin receptor gene polymorphism (rs2293275) with polycystic ovarian syndrome. Genet Test Mol Biomarkers. 19(3):128–132.
   PubMed Web of Science ®Google Scholar
• Tsutsumi R, Webster NJG. 2015. GnRH pulsatility, the pituitary response and reproductive dysfunction. Endocr J. 56(6):729–737.
   Google Scholar
• Valkenburg O, Uitterlinden AG, Piersma D, Hofman A, Themmen AP, de Jong FH, Fauser BC, Laven JS. 2009. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Hum Reprod. 24(8):2014–2022.
   PubMed Web of Science ®Google Scholar
• Wongwananuruk T, Rattanachaiyanont M, Leerasiri P, Indhavivadhana S, Techatraisak K, Angsuwathan S, Tanmahasamut P, Dangrat C. 2012. The usefulness of Homeostatic Measurement Assessment-Insulin Resistance (HOMA-IR) for detection of glucose intolerance in thai women of reproductive age with polycystic ovary syndrome. Int J Endocrinol. 2012:1–6.
   Google Scholar
• Yao K, Bian C, Zhao X. 2017. Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: aggravated complication of pregnancy (Review). Exp Ther Med. 14:1271–1276.
   PubMed Web of Science ®Google Scholar
• Young KA, Chafn CL, Molskness TA, Stouffer RL. 2003. Controlled ovulation of the dominant follicle: a critical role for LH in the late follicular phase of the menstrual cycle. Hum Reprod. 18(11):2257–2263.
   PubMed Web of Science ®Google Scholar
• Zhang F, Du J, Wang B, Wen H, Jia X, Chen H, Deng X. 2017. Dynamics of hormonal profile and anti-mullerian hormone during spontaneous ovulation in PCOS women with oligomenorrhea. Biomed Res. 28:6.
   Google Scholar